机译:自身免疫聚心综合征2型患者2例奥马拉姆治疗严重过敏性哮喘
Department of Internal Medicine Jagiellonian University Medical College;
Department of Internal Medicine Jagiellonian University Medical College;
Department of Internal Medicine Jagiellonian University Medical College;
Department of Internal Medicine Jagiellonian University Medical College;
Department of Internal Medicine Jagiellonian University Medical College;
Department of Internal Medicine Jagiellonian University Medical College;
Department of Internal Medicine Jagiellonian University Medical College;
Department of Internal Medicine Jagiellonian University Medical College;
Autoimmune polyendocrine syndrome type 2; omalizumab; asthma;
机译:自身免疫聚心综合征2型患者2例奥马拉姆治疗严重过敏性哮喘
机译:血浆Galectin-3和尿素蛋白质组学预测omalizumab治疗的严重过敏性哮喘患者的FEV1改善:Proxima子研究结果
机译:综合治疗中度至重度过敏性哮喘患者的患者报告的结果:随机对照试验的系统文献综述
机译:omazulimab治疗严重持续不受控制的过敏性过敏性哮喘的性能健康数据减少的连接
机译:奥马珠单抗对IgE水平升高的过敏性哮喘患者中游离IgE和肺活量测定的影响。
机译:血浆Galectin-3和尿液蛋白质组学预测奥马珠单抗治疗的严重过敏性哮喘患者的FEV1改善:PROXIMA子研究的结果
机译:血浆Galectin-3和尿素蛋白质组学预测omalizumab治疗的严重过敏性哮喘患者的FEV1改善:Proxima子研究结果